Open Access

Long-term effects of a single adult methamphetamine challenge: Minor impact on dopamine fibre density in limbic brain areas of gerbils

  • Susanne Brummelte1,
  • Thorsten Grund1,
  • Andrea Czok1,
  • Gertraud Teuchert-Noodt1 and
  • Jörg Neddens1, 2Email author
Behavioral and Brain Functions20062:12

DOI: 10.1186/1744-9081-2-12

Received: 10 November 2005

Accepted: 28 March 2006

Published: 28 March 2006

Abstract

Background

The aim of the study was to test long-term effects of (+)-methamphetamine (MA) on the dopamine (DA) innervation in limbo-cortical regions of adult gerbils, in order to understand better the repair and neuroplasticity in disturbed limbic networks.

Methods

Male gerbils received a single high dose of either MA (25 mg/kg i.p.) or saline on postnatal day 180. On postnatal day 340 the density of immunoreactive DA fibres and calbindin and parvalbumin cells was quantified in the right hemisphere.

Results

No effects were found in the prefrontal cortex, olfactory tubercle and amygdala, whereas the pharmacological impact induced a slight but significant DA hyperinnervation in the nucleus accumbens. The cell densities of calbindin (CB) and parvalbumin (PV) positive neurons were additionally tested in the nucleus accumbens, but no significant effects were found. The present results contrast with the previously published long-term effects of early postnatal MA treatment that lead to a restraint of the maturation of DA fibres in the nucleus accumbens and prefrontal cortex and a concomitant overshoot innervation in the amygdala.

Conclusion

We conclude that the morphogenetic properties of MA change during maturation and aging of gerbils, which may be due to physiological alterations of maturing vs. mature DA neurons innervating subcortical and cortical limbic areas. Our findings, together with results from other long-term studies, suggest that immature limbic structures are more vulnerable to persistent effects of a single MA intoxication; this might be relevant for the assessment of drug experience in adults vs. adolescents, and drug prevention programs.

Background

Methamphetamine (MA) is a common illicit drug, which abuse is currently reaching epidemic proportions. According to the 2002 SAMHSA National Household Survey on Drug Abuse, 12.4 million Americans age 12 and older had tried methamphetamine at least once in their lifetimes (5.3 percent of the population). This increasing number is especially alarming since it has been extensively shown that MA exerts acute neurotoxic effects on the monoaminergic transmitter systems, and thus leads to characteristic cognitive impairments like deficits in memory and learning, psychomotor speed and information processing [1]. It is especially affecting the dopamine (DA) neurons, leading to dramatic loss of fibres and other DAergic structures in certain brain areas within a few days [2, 3], even after a single exposure [4].

Some evidence exists that monoaminergic fibres are able to recover to some extend from this damage during long time course [59]. Moreover, even reactive overshoot was found for serotonergic fibres in several limbic areas of the brain, including left entorhinal cortex [10] and the septal pole of the hippocampal dentate gyrus [11]. For DA fibres, an early MA treatment produces hyperinnervation in amygdaloid nuclei and ventral entorhinal cortex [12] and a restraint of the maturation in prefrontal cortex [13, 14]. This lab has further shown that the single early MA intoxication produces a loss of DA fibres and concomitant hyperinnervation of serotonin fibres in the nucleus accumbens (NAC) [15].

Taken together, our recent studies indicate severe changes in the maturation of the limbo-cortical network following an early single MA challenge. However, a primary study has already shown that the neuroplasticity that follows MA treatment might relate on the age of the animals [4]. Since the functional maturation and aging of the brain is based on various structural and physiological changes, the present study was carried out to question whether the remodelling of neural networks that is induced by the neurotoxic effects of MA may alter during the lifespan of gerbils. For that purpose, 6 months old adult gerbils received a single high dose of MA. At the age of 12 months the DA innervation was examined in prefrontal cortex, olfactory tubercle, NAC, and amygdala to check for long-time effects on the fibre density.

Methods

All experimental procedures were approved by the appropriate committee for animal care in accordance with the guidelines of the European Communities Council Directive. Breeding gerbils (Meriones unguiculatus) were obtained from Harlan Winkelmann (Borchen, Germany). From offspring, a total of 18 males (weight 66–91 g; age 331–348 days) were used in this study. Young animals were weaned at postnatal day 30 and subsequently separated in standard cages (Macrolon® type 4) without any content except of sawdust. All animals had free access to food and water and were kept on natural day/night cycles. On postnatal day 180, a total of 9 gerbils received a single systemic injection of (+)-methamphetamine hydrochloride (Sigma, M 8750; 25 mg/kg, i.p.). The other 9 animals were sham-treated by an i.p. injection of saline. This dose was chosen due to our former experiences, which have shown that juvenile gerbils can tolerate higher doses (50 mg/kg) than older ones. Notably, the rate of mortality is similar at both ages receiving the different doses (unpublished data), indicating physiological changes during the postnatal maturation of the brain.

The methods used for sectioning and DA immunohistochemistry have been published recently [15]. For the immunohistochemistry of calbindin and parvalbumin cells, 50 μm thick vibratome sections were taken from the same animals (perfused with 100 ml 0.1 M sodium cacodylate pH 6.2, followed by 750 ml 5% glutaraldehyde in 0.1 M sodium cacodylate pH 7.6) and treated as follows: Every third section was collected in 0.05 M Tris-HCL buffered saline [TBS (pH 7.5)] at 4°C; rinsed 3 × 10 min in TBS; incubated 10 min with 1% H2O2 in TBS; rinsed again 3 × 10 min in TBS; blocked in 10% normal goat serum and 0.4% Triton X-100 (Sigma) for 30 min; incubated with the primary antibody (1:3,000 mouse anti-calbindin, Sigma; 1:2,000 mouse anti-parvalbumin, Sigma) in 1% normal goat serum and 0.4% Triton X-100 for 18 h; rinsed 3 × 10 min in TBS; incubated for 30 min in biotinylated goat-anti-mouse antibody (Sigma) diluted 1:20 with 1% normal goat serum; rinsed 3 × 10 min in TBS; incubated with ExtraAvidin-Peroxidase (Sigma) diluted 1:20 for 30 min; rinsed 3 × 10 min in TBS; stained in 0.05% 3.3-diaminobenzidine (Sigma) with 0.01% H2O2 for 4 min. Finally, the sections were rinsed 5 × 10 min in TBS, mounted on glass slides, dried overnight, dehydrated with ethanol, cleared with xylene and cover slipped with DePeX (Serva, Heidelberg, Germany). To avoid deviations due to probably lateralised innervation densities of DA or calcium-binding proteins only right hemispheres were used for quantification.

For quantification of fibre and cell densities, brain sections were chosen in areas of interest by means of anatomical characteristics according to brain atlases of the rat [16] and the mouse [17]. The identification of the brain region follows the nomenclature of the atlas of the rat. The average number of analysed sections was 18 per animal for DA, with a range of 4 up to 6 sections in single regions. In the defined region of each section (cf. Fig. 1) all detectable fibre fragments and cells were visualised in standard test fields (2,080 × 1,544 pixel; 0.22 mm2) using a bright field microscope (BX61, Olympus, Hamburg, Germany) and a digital camera for microscopy (ColorView II, SIS, Münster, Germany) at 200-fold magnification. Cells and fibres were quantified by software for image analysis (KS300, Jenoptik, Jena, Germany). Immunoreactive DA fibres of different diameter were standardised to identical thickness and visualised using a combination of Gauss filter and Gerig operator that depicts differences of grey values of adjacent pixels and transforms the result into binary images. The DA fibre density was computed as a percentage of the evaluated test area. Calbindin and parvalbumin positive cells were detected by use of a threshold to the grey value, followed by automatic sorting of adequate shape and minimal size (250 pixels) of the structures. Remaining structures were classified as cells, the size of the structures (cell area) being measured cumulatively and the according cell density calculated by proportion of cell number per test field area. Calbindin-positive cells are located almost exclusively in the core region of the NAC and were measured only in this part of the NAC, whereas medium-sized PV-positive cells are specific to the shell and were counted only in this area. All analyses were done by a person blind to the pharmacological treatment of individual animals.
Figure 1

Dopamine immunoreactive fibres in each of the quantified regions. Representative photomicrographs, taken from a saline control, of dopamine (DA) immunoreactive fibres of each of the quantified regions. A.1: Prefrontal cortex; A.2: Layer VI of the prelimbic area; A.3: Layer IV of the lateral orbital and agranular insular areas. B.1: Nucleus accumbens (NAC); B.2: Medial shell of NAC; B.3: Lateral core of NAC; B.4: Olfactory tubercle. C.1: Amygdala (AMY); C.2: Central nucleus of AMY; C.3: Basolateral nucleus of AMY. Note the differential innervation pattern and density of DA fibres in the respective regions. Scale bars: 1000 μm (A.1, B.1, C.1); 50 μm (A.2-3, B.2-4, C.2-3).

The measurements were computed as arithmetic means by-case and by-group ± S.E.M. of the respective regions (Fig. 3). Statistical analysis revealed regional effects of MA treatment by the use of Student's t-test. General alterations in the NAC were additionally investigated by use of 2-way analysis of variance (ANOVA), which checked for area-specific and group-specific effects [18]. Data analysis was computed with Statistica 6 (StatSoft, Tulsa, USA). The levels of significance were set at * p < 0.05, ** p < 0.01, and *** p < 0.001.
Figure 3

Dopamine innervation density in four regions of the gerbil brain. Dopamine (DA) innervation density ± S.E.M. is presented in four regions of the gerbil brain, namely agranular insular and lateral orbital as well as prelimbic areas of the prefrontal cortex, the olfactory tubercle, core and shell areas of the nucleus accumbens (NAC), and the central and basolateral nuclei of the amygdala complex. Methamphetamine treatment generally tends to increase the DA innervation. However, a significant region-specific change in response to a single adult methamphetamine treatment exclusively occurs in the shell of the NAC (+11%; p = 0.0332). The difference in the core appears somewhat more pronounced but is not significant due to higher variance (+21%; p = 0.1011). Student's t-Test, significance value: * p < 0.05. Following methamphetamine treatment, ANOVA detected a significant overall increase of DA innervation in core and shell of the NAC (F(1,16) = 4.7316; p = 0.0472).

Results

The innervation pattern of DA immunoreactive fibres in gerbils is generally in line with the results of rats. The innervation pattern and density of DA immunoreactive fibres in the gerbil forebrain are region-specific (Figs. 1 and 3). Representative photographs of the differential DA innervation densities and patterns of the four regions that were subsequently studied in more detail are provided in Fig. 1, taken from a male gerbil of the saline group.

Quantitative DA data were obtained from a total of 327 sections that derived from 18 gerbils of two experimental groups (Saline n = 9, MA n = 9). The adult single systemic MA challenge induces no general alteration of DA innervation pattern in the investigated regions of the gerbil brain (Fig. 3). The overall DA fibre density in the NAC is selectively increased by MA [(ANOVA, F(1,16) = 4.7316, p = 0.0472) please note that ANOVA included comparison of 8 vs. 8 animals only, because some NAC sections were damaged in one animal of each experimental group]. However, the significant increase (+11%) is limited to the shell (Student's t-test, p = 0.0332), whereas alteration in the core misses statistical significance (Student's t-test, p = 0.1011). No change in DA fibre density was found in the prefrontal cortex, olfactory tubercle and amygdala.

To determine other potential alterations within the NAC, CB- and PV- positive structures were additionally investigated in this area. The distribution of CB- and PV-positive subpopulations in the gerbil generally resembles the distribution in the NAC of rats and primates (Fig. 2) [1921]. A single adult MA intoxication caused no significant alteration in the cell density of either CB- positive neurons or PV-positive neurons in the NAC. Neither was there a difference in the cell areas (Fig. 4).
Figure 2

Photomicrographs of Calbindin and Parvalbumin immunoreactive neurons in the nucleus accumbens. Overview (A) and higher magnifications (A1, A2) of the Calbindin innervation of the NAC. The majority of CB+ cells is located in the core, which border to the shell is detectable (black arrows). PV+ cells are almost exclusively located in the shell (B1, B2), however, the overall density is much lower compared to CB+ cells. Scale bars: 2000 μm (A, B); 200 μm (A1, B1); 100 μm (A2, B2).

Figure 4

Calbindin and parvalbumin cell densities and cell areas in the nucleus accumbens. Calbindin (CB) and parvalbumin (PV) cell densities and cell areas ± S.E.M. are presented for the nucleus accumbens (NAC). PV-positive cells and CB-positive cells are predominantly located in the shell and in the core of the NAC, respectively, where they were quantified. No statistically significant effect of a single adult methamphetamine challenge could be detected for either number (cell density) or cumulative size (cell area) of both PV and CB cells. Generally, the number of CB cells is considerably higher and their average size is doubled compared to PV cells.

Discussion

According to our results, a single adult MA challenge induces minor long-term changes of the DA innervation in the NAC, whereas other regions of the limbocortical circuitry are apparently unaffected. These results contrast with previously published data on the long-term effects of early postnatal MA treatment that demonstrated a restraint maturation of DAergic fibres in the NAC and the prefrontal cortex [14, 22] and a concomitant overshoot innervation in the amygdala [12]. Table 1 provides a comparison between MA effects on DA innervation in juvenile and adult gerbils.
Table 1

Comparison of age-related long-term effects of a single methamphetamine intoxication on the dopamine innervation in limbocortical areas of the gerbil brain.

  

Adult (current study) MA 1 × 25 mg/kg i.p., p180

Juvenile [Reference] MA 1 × 50 mg/kg i.p., p14

Prefrontal cortex

Medial

↔ n.s.

↓ – 38% ** [14]

 

Orbital

↔ n.s.

↓ – 50% ** [14]

Nucleus accumbens

Core

↔ n.s.

↓ – 28% * [15]

 

Shell

↑ +11% *

↔ n.s. [15]

Amygdala

Basolateral

↔ n.s.

↑ +18% ** [12]

 

Central

↔ n.s.

↔ n.s. [12]

Olfactory Tubercle

 

↔ n.s

No data

Significance values: * p < 0.05, ** p < 0.01.

Postnatal development and vulnerability to methamphetamine

The age-related and region-specific alterations that are triggered by a single MA-treatment of gerbils might reveal the complexity of MA neurotoxicity. It has to be pointed out that the different doses that were administered to juvenile (50 mg/kg) [1015, 22] vs. adult (25 mg/kg, current study) animals may be even more adequate for comparing age-related effects than using the same dose in both ages, because a lethal dose of MA is approximately also twice as high in juvenile gerbils compared to adults (unpublished data), indicating physiological changes during postnatal maturation of the brain. The reasons for the age-dependent differences in vulnerability to MA in gerbils are currently not clear. However, it appears reasonable to assume that this is related to physiological alterations in maturing vs. mature monoaminergic neurons. Generally, the high amount of MA that is required to induce such effects might be specific to gerbils, probably due to species-specific metabolic enzymes.

Although the exact molecular mechanism of MA neurotoxicity is still not completely understood, it is clear that developmental alteration must play an important role in mediating the MA-induced effects [23]. This is demonstrated by the finding that the application of MA results in higher mortality and stronger reactions of adult gerbils compared to juveniles or adolescents [4, 2429], which may be understandable by reports that, in rats, higher MA concentrations occur in the brains of 90 days old versus 40 days old animals after receiving the same dose [25, 29]. However, Kokoshka and colleagues published some intriguing results which on the one hand confirmed previous studies concerning the lack of medium-term (7 days) deficits in the DA systems after MA treatment in adolescent rats, but on the other hand showed that there were acute short-term (1 hour) consequences in adolescent (40 days) and adult (90 days) rats [25]. Further, MA-induced behavioural sensitization, which is a prominent feature of MA administration [30, 31], seems to be age-dependent [32]. It does not occur within a crucial postnatal period, which in turn seems to correspond to the time of presynaptic DA autoreceptor formation in the brain [33].

Several parameters of the DA system underlie developmental changes, e.g. DAT expression [34, 35], expression of DA receptors and DA concentration [36], and activity of the vesicular monoamine transporter-2 (VMAT-2) [29]. The mechanism underlying the modifications seen in adult animals after MA challenge is therefore thought to vary from the one mediating the neurotoxic effect in juvenile animals. The ability of a single early MA challenge to selectively induce a restraint of the maturation of DA fibres in the prefrontal cortex and the NAC [14, 22, 37] as well as a concomitant excessive maturation in several amygdaloid nuclei and the entorhinal cortex [12] might be due to a special vulnerability of immature fibre systems [38]. As DA transmission in the NAC seems to play a critical role in an input selection mechanism that regulates the influence of certain inputs over neural activity [39], the reactive changes that occur within local circuits following the MA challenge might cause a new and different innervation pattern of these fibres and thus a neuroanatomical restructuring [40, 41]. The severe impairment of the brain architecture induced by a single early MA treatment clearly demonstrates that despite the apparent higher resistance of younger animals, MA is indeed a potent drug capable of inducing extensive structural alterations in the juvenile brain that persist into adulthood.

Effects of methamphetamine on different neurotransmitters and brain regions

It was reported that the mechanism of MA neurotoxicity includes the formation of reactive oxygen [4244] and nitrogen [42, 45, 46] species, which damage monoaminergic neurons. However, several other factors may also contribute in mediating the neurotoxic effect of MA, leading to region-specific and neuron-specific differences in vulnerability. Fumagalli and colleagues have shown that rats lacking the dopamine transporter (DAT) are protected against the MA-related neurotoxicity in the striatum [47]. Interestingly, impairment in the function of VMAT-2, which accumulates cytoplasmic DA into synaptic vesicles as seen in mice heterozygous for this transporter, increases the MA neurotoxicity [48]. It has also been demonstrated that the blockage of either DA D1 or D2 receptors prevents the damage of repeated doses of MA to striate DA terminals [49] and that there are regional differences in sensitivity of these terminals to the MA [4, 50]. It seems likely that DAT and DA receptors may be factors limiting the severity of neurotoxic effects of MA, presumably by influencing the concentration and distribution of DA.

MA-induced alterations have also been found in other neuronal elements like 5-HT fibres [10, 15, 51, 52], GABAergic neurons [53], and the morphology of cortical pyramidal cells [54]. Our animal model has also revealed that glutamatergic projection fibres from the mediodorsal prefrontal cortex to several other cortical areas are significantly reduced after an early single MA intoxication [55]. Interestingly, in the present study the shell of the NAC is the only area that reacts to a single adult MA challenge, and it is also almost the only area we have studied lacking any effect of the DA fibre density in response to a single postnatal drug treatment [12, 14, 15] (cf. Table 1). In contrast, the core region of the NAC exhibits a strong decline in DA fibre density after an early single MA administration [15]. This is in line with results from Broening and colleagues, who, after repeated MA treatment of rats, found an almost completely loss of tyrosine hydroxylase immunoreactivity in the core while the shell was almost spared [56]. In addition, most drugs increase extracellular DA levels preferentially in the shell region of the NAC [57], which coincides with differences in DA baseline levels [57, 58], and different time-course of the maturation of the DA innervation in the core and shell areas [59]. We may conclude that the DA fibre systems of the brain are far from being homogeneous; thus, statements on the general effects of MA intoxication on DA fibres are misleading.

Regeneration and reorganisation of neural networks: implications for psychiatric diseases

It has been shown before that DA fibres can be rebuilt within 24 weeks after a lesion of the NAC with 6-OHDA [60]. Furthermore, Finkelstein and colleagues could show that a lesion to the substantia nigra causes sprouting of DA fibres in the striatum of rats [61]. Thus, the increased fibre density we have found in the NAC might probably be caused by a specific regeneration rather than a reorganisation of fibres.

Several studies in humans and rodents have shown that the effects of MA are to a large extend reversible, although this process might last many years and may strongly depend on the severity and duration of the drug abuse [1]. We have shown that a single administration of MA on postnatal day 90 leads to a transient increase of the dendritic spine density of prefrontal pyramidal neurons, which regain an almost normal level within 30 days post-treatment [62]. In the present study, we apparently provided sufficient time for the impaired system to recover from MA intoxication and to eventually regain normal DA fibre densities. Our model using only a single administration of MA may therefore be more useful to mimic the effects on first time users rather than on chronically abusers of the drug. In addition, it has been shown that intermittent treatment with MA can lead to the development of tolerance to its neurotoxic effects [6365]. Thus the paradigm of repeated administration of MA as used in the majority of studies might either conceal or modify the deleterious effects of the psychostimulant. In fact, some studies have shown opposed or stronger effects of single versus chronic administration of MA [66, 67].

Chronic MA use is known to cause psychotic symptoms that mimic that of schizophrenia [6870]. Further, we could recently show that an early single intoxication leads to a 'dysconnection' of prefrontal efferents [55], thus providing an anatomical correlate of schizophrenia [71, 72]. This is consistent with results from Chen and colleagues who revealed an association between earlier and larger use of MA with higher risk of psychosis in humans [68].

Conclusion

The results of this study show that even a single application of MA to adult gerbils may induce long-term physical alterations in limbic brain areas, although the effects are not as severe as seen after an early drug challenge. The increased DAergic fibre density in the NAC indicates reactive over-sprouting, which possibly is a response to altered network requirements after MA treatment. It remains to be investigated whether other brain areas would reveal short-term modifications, which might be concealed by recovery in this approach. While it cannot be excluded that the different effects in adult vs. juvenile gerbils are, at least in part, due to the different doses of MA, several other studies also indicate changes in MA effects that depend on the age of rats and mice. We thus may conclude that, in rodents, MA not only acts age-dependent, but also highly region-specific. We have sufficient evidence to suggest that early contact with this psychotropic substance during childhood might increase the risk of persistent severe structural changes of the brain architecture and may result in long-term cognitive and psychiatric disturbances.

Declarations

Acknowledgements

The authors would like to thank Ulrike Schroeder and Francesco Bagorda for excellent technical assistance. The study was supported by grants of the deutsche Parkinson Vereinigung (dPV).

Authors’ Affiliations

(1)
Department of Neuroanatomy, Faculty of Biology, University of Bielefeld
(2)
National Institutes of Health, NICHD, Section on Molecular Neurobiology

References

  1. Meredith CW, Jaffe C, Ang-Lee K, Saxon AJ: Implications of chronic methamphetamine use: a literature review. Harv Rev Psychiatry. 2005, 13: 141-154. 10.1080/10673220591003605.View ArticlePubMedGoogle Scholar
  2. Ricaurte GA, Guillery RW, Seiden LS, Schuster CR, Moore RY: Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res. 1982, 235: 93-103. 10.1016/0006-8993(82)90198-6.View ArticlePubMedGoogle Scholar
  3. Ricaurte GA, Schuster CR, Seiden LS: Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: a regional study. Brain Res. 1980, 193: 153-163. 10.1016/0006-8993(80)90952-X.View ArticlePubMedGoogle Scholar
  4. Teuchert-Noodt G, Dawirs RR: Age-related toxicity in prefrontal cortex and caudate-putamen complex of gerbils (Meriones unguiculatus) after a single dose of methamphetamine. Neuropharmacology. 1991, 30: 733-743. 10.1016/0028-3908(91)90181-A.View ArticlePubMedGoogle Scholar
  5. Cass WA, Manning MW: Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine. J Neurosci. 1999, 19: 7653-7660.PubMedGoogle Scholar
  6. Cass WA: Attenuation and recovery of evoked overflow of striatal serotonin in rats treated with neurotoxic doses of methamphetamine. J Neurochem. 2000, 74: 1079-1085. 10.1046/j.1471-4159.2000.0741079.x.View ArticlePubMedGoogle Scholar
  7. Friedman SD, Castaneda E, Hodge GK: Long-term monoamine depletion, differential recovery, and subtle behavioral impairment following methamphetamine-induced neurotoxicity. Pharmacol Biochem Behav. 1998, 61: 35-44. 10.1016/S0091-3057(98)00066-5.View ArticlePubMedGoogle Scholar
  8. Woolverton WL, Ricaurte GA, Forno LS, Seiden LS: Long-term effects of chronic methamphetamine administration in rhesus monkeys. Brain Res. 1989, 486: 73-78. 10.1016/0006-8993(89)91279-1.View ArticlePubMedGoogle Scholar
  9. Sabol KE, Richards JB, Yung K: The effects of high-dose methamphetamine in the aging rat: differential reinforcement of low-rate 72-s schedule behavior and neurochemistry. J Pharmacol Exp Ther. 2000, 294: 850-863.PubMedGoogle Scholar
  10. Neddens J, Dawirs RR, Bagorda F, Busche A, Horstmann S, Teuchert-Noodt G: Postnatal maturation of cortical serotonin lateral asymmetry in gerbils is vulnerable to both environmental and pharmacological epigenetic challenges. Brain Res. 2004, 1021: 200-208. 10.1016/j.brainres.2004.06.050.View ArticlePubMedGoogle Scholar
  11. Busche A, Neddens J, Dinter C, Dawirs RR, Teuchert-Noodt G: Differential influence of rearing conditions and methamphetamine on serotonin fibre maturation in the dentate gyrus of gerbils (Meriones unguiculatus). Dev Neurosci. 2002, 24: 512-521. 10.1159/000069362.View ArticlePubMedGoogle Scholar
  12. Busche A, Polascheck D, Lesting J, Neddens J, Teuchert-Noodt G: Developmentally induced imbalance of dopaminergic fibre densities in limbic brain regions of gerbils (Meriones unguiculatus). J Neural Transm. 2004, 111: 451-463. 10.1007/s00702-004-0106-2.View ArticlePubMedGoogle Scholar
  13. Dawirs RR, Teuchert-Noodt G, Nossoll M: Pharmacologically induced neural plasticity in the prefrontal cortex of adult gerbils (Meriones unguiculatus). Eur J Pharmacol. 1997, 327: 117-123. 10.1016/S0014-2999(97)89650-1.View ArticlePubMedGoogle Scholar
  14. Dawirs RR, Teuchert-Noodt G, Czaniera R: The postnatal maturation of dopamine innervation in the prefrontal cortex of gerbils (Meriones unguiculatus) is sensitive to an early single dose of methamphetamine. A quantitative immunocytochemical study. J Hirnforsch. 1994, 35: 195-204.PubMedGoogle Scholar
  15. Lesting J, Neddens J, Busche A, Teuchert-Noodt G: Hemisphere-specific effects on serotonin but not dopamine innervation in the nucleus accumbens of gerbils caused by isolated rearing and a single early methamphetamine challenge. Brain Res. 2005, 1035: 168-176. 10.1016/j.brainres.2004.12.005.View ArticlePubMedGoogle Scholar
  16. Paxinos G, Watson C: The rat brain in stereotaxic coordinates. 1986, New York: Academic PressGoogle Scholar
  17. Valverde F: Golgi atlas of the postnatal mouse brain. 1998, Wien, New York: Springer-VerlagView ArticleGoogle Scholar
  18. Stahel WA: Statistische Datenanalyse: eine Einführung für Naturwissenschaftler. 1999, Braunschweig: ViewegView ArticleGoogle Scholar
  19. Cote PY, Sadikot AF, Parent A: Complementary Distribution of Calbindin D-28k and Parvalbumin in the Basal Forebrain and Midbrain of the Squirrel Monkey. Eur J Neurosci. 1991, 3: 1316-1329.View ArticlePubMedGoogle Scholar
  20. Meredith GE, Pattiselanno A, Groenewegen HJ, Haber SN: Shell and core in monkey and human nucleus accumbens identified with antibodies to calbindin-D28k. J Comp Neurol. 1996, 365: 628-639. 10.1002/(SICI)1096-9861(19960219)365:4<628::AID-CNE9>3.0.CO;2-6.View ArticlePubMedGoogle Scholar
  21. Zahm DS, Brog JS: On the significance of subterritories in the "accumbens" part of the rat ventral striatum. Neuroscience. 1992, 50: 751-767. 10.1016/0306-4522(92)90202-D.View ArticlePubMedGoogle Scholar
  22. Neddens J, Lesting J, Dawirs RR, Teuchert-Noodt G: An early methamphetamine challenge suppresses the maturation of dopamine fibres in the nucleus accumbens of gerbils: on the significance of rearing conditions. J Neural Transm. 2002, 109: 141-155. 10.1007/s007020200010.View ArticlePubMedGoogle Scholar
  23. Frost DO, Cadet JL: Effects of methamphetamine-induced neurotoxicity on the development of neural circuitry: a hypothesis. Brain Res Brain Res Rev. 2000, 34: 103-118. 10.1016/S0165-0173(00)00042-4.View ArticlePubMedGoogle Scholar
  24. Gomes-da-Silva J, de MR, Fernandez-Ruiz J, Summavielle T, Tavares MA: Effects of neonatal exposure to methamphetamine: catecholamine levels in brain areas of the developing rat. Ann N Y Acad Sci. 2004, 1025: 602-611. 10.1196/annals.1316.075.View ArticlePubMedGoogle Scholar
  25. Kokoshka JM, Fleckenstein AE, Wilkins DG, Hanson GR: Age-dependent differential responses of monoaminergic systems to high doses of methamphetamine. J Neurochem. 2000, 75: 2095-2102. 10.1046/j.1471-4159.2000.0752095.x.View ArticlePubMedGoogle Scholar
  26. Miller DB, O'Callaghan JP, Ali SF: Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure. Ann N Y Acad Sci. 2000, 914: 194-207.View ArticlePubMedGoogle Scholar
  27. Cappon GD, Morford LL, Vorhees CV: Ontogeny of methamphetamine-induced neurotoxicity and associated hyperthermic response. Brain Res Dev Brain Res. 1997, 103: 155-162. 10.1016/S0165-3806(97)81791-9.View ArticlePubMedGoogle Scholar
  28. Pu C, Vorhees CV: Developmental dissociation of methamphetamine-induced depletion of dopaminergic terminals and astrocyte reaction in rat striatum. Brain Res Dev Brain Res. 1993, 72: 325-328. 10.1016/0165-3806(93)90201-K.View ArticlePubMedGoogle Scholar
  29. Truong JG, Wilkins DG, Baudys J, Crouch DJ, Johnson-Davis KL, Gibb JW, Hanson GR, Fleckenstein AE: Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicity. J Pharmacol Exp Ther. 2005, 314: 1087-1092. 10.1124/jpet.105.085951.View ArticlePubMedGoogle Scholar
  30. Akiyama K, Kanzaki A, Tsuchida K, Ujike H: Methamphetamine-induced behavioral sensitization and its implications for relapse of schizophrenia. Schizophr Res. 1994, 12: 251-257. 10.1016/0920-9964(94)90035-3.View ArticlePubMedGoogle Scholar
  31. Chiu CT, Ma T, Ho IK: Attenuation of methamphetamine-induced behavioral sensitization in mice by systemic administration of naltrexone. Brain Res Bull. 2005, 67: 100-109. 10.1016/j.brainresbull.2005.05.028.PubMed CentralView ArticlePubMedGoogle Scholar
  32. Kuribara H, Yasuda H, Uchihashi Y: Age-dependent induction and maintenance of sensitization to methamphetamine-induced hyperactivity in mice. Psychiatry Clin Neurosci. 1996, 50: 299-303.View ArticlePubMedGoogle Scholar
  33. Fujiwara Y, Kazahaya Y, Nakashima M, Sato M, Otsuki S: Behavioral sensitization to methamphetamine in the rat: an ontogenic study. Psychopharmacology (Berl). 1987, 91: 316-319. 10.1007/BF00518183.View ArticleGoogle Scholar
  34. Coulter CL, Happe HK, Murrin LC: Dopamine transporter development in postnatal rat striatum: an autoradiographic study with [3H]WIN 35,428. Brain Res Dev Brain Res. 1997, 104: 55-62. 10.1016/S0165-3806(97)00135-1.View ArticlePubMedGoogle Scholar
  35. Moll GH, Mehnert C, Wicker M, Bock N, Rothenberger A, Ruther E, Huether G: Age-associated changes in the densities of presynaptic monoamine transporters in different regions of the rat brain from early juvenile life to late adulthood. Brain Res Dev Brain Res. 2000, 119: 251-257. 10.1016/S0165-3806(99)00182-0.View ArticlePubMedGoogle Scholar
  36. Noisin EL, Thomas WE: Ontogeny of dopaminergic function in the rat midbrain tegmentum, corpus striatum and frontal cortex. Brain Res. 1988, 469: 241-252.View ArticlePubMedGoogle Scholar
  37. Neddens J, Brandenburg K, Teuchert-Noodt G, Dawirs RR: Differential environment alters ontogeny of dopamine innervation of the orbital prefrontal cortex in gerbils. J Neurosci Res. 2001, 63: 209-213. 10.1002/1097-4547(20010115)63:2<209::AID-JNR1013>3.0.CO;2-E.View ArticlePubMedGoogle Scholar
  38. Benes FM: The role of stress and dopamine-GABA interactions in the vulnerability for schizophrenia. J Psychiatr Res. 1997, 31: 257-275. 10.1016/S0022-3956(96)00044-1.View ArticlePubMedGoogle Scholar
  39. Floresco SB, Blaha CD, Yang CR, Phillips AG: Modulation of hippocampal and amygdalar-evoked activity of nucleus accumbens neurons by dopamine: cellular mechanisms of input selection. J Neurosci. 2001, 21: 2851-2860.PubMedGoogle Scholar
  40. Teuchert-Noodt G: Neuronal degeneration and reorganization: a mutual principle in pathological and in healthy interactions of limbic and prefrontal circuits. J Neural Transm Suppl. 2000, 315-333.Google Scholar
  41. Bennay M, Gernert M, Schwabe K, Enkel T, Koch M: Neonatal medial prefrontal cortex lesion enhances the sensitivity of the mesoaccumbal dopamine system. Eur J Neurosci. 2004, 19: 3277-3290. 10.1111/j.0953-816X.2004.03442.x.View ArticlePubMedGoogle Scholar
  42. Cadet JL, Brannock C: Free radicals and the pathobiology of brain dopamine systems. Neurochem Int. 1998, 32: 117-131. 10.1016/S0197-0186(97)00031-4.View ArticlePubMedGoogle Scholar
  43. Gluck MR, Moy LY, Jayatilleke E, Hogan KA, Manzino L, Sonsalla PK: Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment. J Neurochem. 2001, 79: 152-160. 10.1046/j.1471-4159.2001.00549.x.View ArticlePubMedGoogle Scholar
  44. Kita T, Wagner GC, Nakashima T: Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption. J Pharmacol Sci. 2003, 92: 178-195. 10.1254/jphs.92.178.View ArticlePubMedGoogle Scholar
  45. Imam SZ, Newport GD, Itzhak Y, Cadet JL, Islam F, Slikker W, Ali SF: Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase. J Neurochem. 2001, 76: 745-749. 10.1046/j.1471-4159.2001.00029.x.View ArticlePubMedGoogle Scholar
  46. Itzhak Y, Gandia C, Huang PL, Ali SF: Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity. J Pharmacol Exp Ther. 1998, 284: 1040-1047.PubMedGoogle Scholar
  47. Fumagalli F, Gainetdinov RR, Valenzano KJ, Caron MG: Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter. J Neurosci. 1998, 18: 4861-4869.PubMedGoogle Scholar
  48. Fumagalli F, Gainetdinov RR, Wang YM, Valenzano KJ, Miller GW, Caron MG: Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. J Neurosci. 1999, 19: 2424-2431.PubMedGoogle Scholar
  49. O'Dell SJ, Weihmuller FB, Marshall JF: Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists. J Neurochem. 1993, 60: 1792-1799.View ArticlePubMedGoogle Scholar
  50. Eisch AJ, Gaffney M, Weihmuller FB, O'Dell SJ, Marshall JF: Striatal subregions are differentially vulnerable to the neurotoxic effects of methamphetamine. Brain Res. 1992, 598: 321-326. 10.1016/0006-8993(92)90201-J.View ArticlePubMedGoogle Scholar
  51. Lehmann K, Lesting J, Polascheck D, Teuchert-Noodt G: Serotonin fibre densities in subcortical areas: differential effects of isolated rearing and methamphetamine. Brain Res Dev Brain Res. 2003, 147: 143-152. 10.1016/S0165-3806(03)00130-5.View ArticlePubMedGoogle Scholar
  52. Neddens J, Bagorda F, Busche A, Horstmann S, Moll GH, Dawirs RR, Teuchert-Noodt G: Epigenetic factors differentially influence postnatal maturation of serotonin (5-HT) innervation in cerebral cortex of gerbils: interaction of rearing conditions and early methamphetamine challenge. Brain Res Dev Brain Res. 2003, 146: 119-130. 10.1016/j.devbrainres.2003.09.016.View ArticlePubMedGoogle Scholar
  53. Nossoll M, Teuchert-Noodt G, Dawirs RR: A single dose of methamphetamine in neonatal gerbils affects adult prefrontal gamma-aminobutyric acid innervation. Eur J Pharmacol. 1997, 340: R3-R5.PubMedGoogle Scholar
  54. Blaesing B, Nossoll M, Teuchert-Noodt G, Dawirs RR: Postnatal maturation of prefrontal pyramidal neurones is sensitive to a single early dose of methamphetamine in gerbils (Meriones unguiculatus). J Neural Transm. 2001, 108: 101-113. 10.1007/s007020170101.View ArticlePubMedGoogle Scholar
  55. Bagorda F, Teuchert-Noodt G, Lehmann K: Isolation rearing or methamphetamine traumatisation induce a "dysconnection" of prefrontal efferents in gerbils: implications for schizophrenia. J Neural Transm. 2006, 113: 365-379. 10.1007/s00702-005-0324-2.View ArticlePubMedGoogle Scholar
  56. Broening HW, Pu C, Vorhees CV: Methamphetamine selectively damages dopaminergic innervation to the nucleus accumbens core while sparing the shell. Synapse. 1997, 27: 153-160. 10.1002/(SICI)1098-2396(199710)27:2<153::AID-SYN6>3.0.CO;2-D.View ArticlePubMedGoogle Scholar
  57. Zocchi A, Girlanda E, Varnier G, Sartori I, Zanetti L, Wildish GA, Lennon M, Mugnaini M, Heidbreder CA: Dopamine responsiveness to drugs of abuse: A shell-core investigation in the nucleus accumbens of the mouse. Synapse. 2003, 50: 293-302. 10.1002/syn.10271.View ArticlePubMedGoogle Scholar
  58. King D, Zigmond MJ, Finlay JM: Effects of dopamine depletion in the medial prefrontal cortex on the stress-induced increase in extracellular dopamine in the nucleus accumbens core and shell. Neuroscience. 1997, 77: 141-153. 10.1016/S0306-4522(96)00421-6.View ArticlePubMedGoogle Scholar
  59. Lesting J, Neddens J, Teuchert-Noodt G: Ontogeny of the dopamine innervation in the nucleus accumbens of gerbils. Brain Res. 2005, 1066: 16-23.View ArticlePubMedGoogle Scholar
  60. Vos PE, Steinbusch HW, van Ree JM: Reinnervation after destruction of the dopaminergic system in the rat nucleus accumbens: a quantitative immunohistochemical analysis. Neurosci Lett. 1996, 207: 21-24. 10.1016/0304-3940(96)12498-8.View ArticlePubMedGoogle Scholar
  61. Finkelstein DI, Stanic D, Parish CL, Tomas D, Dickson K, Horne MK: Axonal sprouting following lesions of the rat substantia nigra. Neuroscience. 2000, 97: 99-112. 10.1016/S0306-4522(00)00009-9.View ArticlePubMedGoogle Scholar
  62. Dawirs RR, Teuchert-Noodt G, Molthagen M: Indication of methamphetamine-induced reactive synaptogenesis in the prefrontal cortex of gerbils (Meriones unguiculatus). Eur J Pharmacol. 1993, 241: 89-97. 10.1016/0014-2999(93)90937-D.View ArticlePubMedGoogle Scholar
  63. Segal DS, Kuczenski R, O'Neil ML, Melega WP, Cho AK: Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge. Neuropsychopharmacology. 2003, 28: 1730-1740. 10.1038/sj.npp.1300247.View ArticlePubMedGoogle Scholar
  64. Segal DS, Kuczenski R: Human Methamphetamine Pharmacokinetics Simulated in the Rat: Single Daily Intravenous Administration Reveals Elements of Sensitization and Tolerance. Neuropsychopharmacology. 2005,Google Scholar
  65. Thomas DM, Kuhn DM: Attenuated microglial activation mediates tolerance to the neurotoxic effects of methamphetamine. J Neurochem. 2005, 92: 790-797. 10.1111/j.1471-4159.2004.02906.x.View ArticlePubMedGoogle Scholar
  66. Ishikawa K, Nitta A, Mizoguchi H, Mohri A, Murai R, Miyamoto Y, Noda Y, Kitaichi K, Yamada K, Nabeshima T: Effects of single and repeated administration of methamphetamine or morphine on neuroglycan C gene expression in the rat brain. Int J Neuropsychopharmacol. 2005,Google Scholar
  67. Zhu JP, Xu W, Angulo N, Angulo JA: Methamphetamine-induced striatal apoptosis in the mouse brain: Comparison of a binge to an acute bolus drug administration. Neurotoxicology. 2005Google Scholar
  68. Chen CK, Lin SK, Sham PC, Ball D, Loh EW, Hsiao CC, Chiang YL, Ree SC, Lee CH, Murray RM: Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychol Med. 2003, 33: 1407-1414. 10.1017/S0033291703008353.View ArticlePubMedGoogle Scholar
  69. Machiyama Y: Chronic methamphetamine intoxication model of schizophrenia in animals. Schizophr Bull. 1992, 18: 107-113.View ArticlePubMedGoogle Scholar
  70. Sato M: A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis. Ann N Y Acad Sci. 1992, 654: 160-170.View ArticlePubMedGoogle Scholar
  71. Feinberg I: Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?. J Psychiatr Res. 1982, 17: 319-334. 10.1016/0022-3956(82)90038-3.View ArticlePubMedGoogle Scholar
  72. Weinberger DR, Lipska BK: Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground. Schizophr Res. 1995, 16: 87-110. 10.1016/0920-9964(95)00013-C.View ArticlePubMedGoogle Scholar

Copyright

© Brummelte et al; licensee BioMed Central Ltd. 2006

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.